OpenClinica Enterprise is being adopted to power clinical trials in Australia and New Zeland by Emphron Informatics, a data management and biostatistics contract research organization (CRO). Full press release within.
(Cambridge, MA) August 13, 2007 � Akaza Research, LLC announced today that OpenClinica Enterprise is being adopted by Emphron Informatics, a data management and biostatistics contract research organization (CRO) in Queensland, Australia. Emphron will use OpenClinica Enterprise to help it better manage its customers� clinical trials throughout Australia and New Zealand.
Since its debut in 2005 OpenClinica adoption has expanded rapidly around the globe to over 30 countries worldwide.
�OpenClinica Enterprise enhances the value we offer to our customers through speed of deployment and higher quality study data,� said Dr. Mervyn Thomas, Biostatistics Partner at Emphron.
Provided by Akaza Research, LLC, OpenClinica Enterprise is a certified, validated, and supported version of OpenClinica, the popular open source clinical data capture system.
“OpenClinica�s lightweight infrastructure and open source licensing model make it very appealing to clinical informatics service providers like Emphron,” said Benjamin Baumann, Akaza�s Director of Business Development. “We look forward to working with the team at Emphron to enhance the productivity of clinical trials in the Australia region,” he added.
About Emphron Informatics
Emphron Informatics provides full data management and statistical analysis services across the range of biological research. Key areas of expertise include biotechnology, clinical research, and environmental studies. The company�s solutions in these areas include data management, and data analysis, system development, and systems integration. For more information see http://www.emphron.com.
OpenClinica is open source web-based electronic data capture software for clinical research. It facilitates protocol configuration, design of case report forms, clinical data capture, and study/data management. OpenClinica supports HIPAA and 21 CFR Part 11 guidelines and is designed as a lightweight, standards-based, extensible, and modular platform. The current production release of OpenClinica is version 2.0.1. All versions of OpenClinica are available for download at www.OpenClinica.org.
About Akaza Research�
Akaza Research, the leading provider of open source clinical trial software, is headquartered in Cambridge, Massachusetts. Supported by the National Institutes of Health (NIH), Akaza has developed and commercialized OpenClinica, the preeminent open source clinical trial data capture and management software platform. Akaza brings Open Source Software (OSS) into the mainstream of the clinical research enterprise by making robust, flexible, standards-based systems accessible for private and public research. Akaza Research provides OpenClinica support, training, and consulting services to its customers worldwide. See www.akazaresearch.com.
# # #